Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

Clinical trial NCT06776783 · RECRUITING

Trial details

NCT number: NCT06776783
Sponsor: Aerogen Pharma Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Distress Syndrome Pre-term Infants

Start date: 2025-09-24
Primary completion: 2027-05-01
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.